Results 191 to 200 of about 333,866 (340)

Patient‐Reported Dysphagia and Swallowing‐Related Quality of Life up to 10 Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross‐Sectional Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background This study sought to better understand patient‐reported dysphagia and swallowing‐related quality of life (swQOL) in patients 6 months to 10 years following definitive (chemo)radiotherapy for head and neck cancer (HNC). Methods In this cross‐sectional study, self‐reported dysphagia was assessed with the Eating Assessment Tool (EAT‐10)
Jacqui J. Frowen   +4 more
wiley   +1 more source

Effectiveness of Pharmaceutical Counseling in Sore Throat Management According to Patients and Pharmacists. [PDF]

open access: yesHealthcare (Basel)
Merks P   +9 more
europepmc   +1 more source

Malignant Transformation of Oral Leukoplakia and Proliferative Verrucous Leukoplakia and Its Biomarker Predictors: A Systematic Umbrella Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Oral leukoplakia (OL) represents the most common oral potentially malignant disorder globally, with highly variable reported malignant transformation (MT) rates creating challenges for evidence‐based clinical management. Objective To systematically synthesize evidence on MT prevalence in OL and evaluate potential predictive ...
Mohammed Taib Fatih   +13 more
wiley   +1 more source

Comparison of nebulized ketamine and ketamine with clonidine in postoperative sore throat

open access: diamond, 2017
Sunita Jain   +5 more
openalex   +1 more source

Man Complaining of Sore Throat. [PDF]

open access: yesJ Am Coll Emerg Physicians Open
Yu J, Sullivan P, Thompson J, Colla JS.
europepmc   +1 more source

Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy